Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Structure ; 30(8): 1050-1054.e2, 2022 08 04.
Artículo en Inglés | MEDLINE | ID: mdl-35609600

RESUMEN

During RNA replication, coronaviruses require proofreading to maintain the integrity of their large genomes. Nsp14 associates with viral polymerase complex to excise the mismatched nucleotides. Aside from the exonuclease activity, nsp14 methyltransferase domain mediates cap methylation, facilitating translation initiation and protecting viral RNA from recognition by the innate immune sensors. The nsp14 exonuclease activity is modulated by a protein co-factor nsp10. While the nsp10/nsp14 complex structure is available, the mechanistic basis for nsp10-mediated modulation remains unclear in the absence of the nsp14 structure. Here, we provide a crystal structure of nsp14 in an apo-form. Comparative analysis of the apo- and nsp10-bound structures explain the modulatory role of the co-factor protein and reveal the allosteric nsp14 control mechanism essential for drug discovery. Further, the flexibility of the N-terminal lid of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nsp14 structure presented in this study rationalizes the recently proposed idea of nsp14/nsp10/nsp16 ternary complex.


Asunto(s)
Exorribonucleasas , Proteínas no Estructurales Virales , Proteínas Reguladoras y Accesorias Virales , Exonucleasas , Exorribonucleasas/química , Metiltransferasas/química , Pliegue de Proteína , ARN Viral/metabolismo , SARS-CoV-2 , Proteínas no Estructurales Virales/química , Proteínas Reguladoras y Accesorias Virales/química
3.
ChemMedChem ; 3(3): 435-44, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18064617

RESUMEN

To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million commercially available compounds 222 552 compounds were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compounds for a focused kinase set. Compiling these libraries required a robust strategy for compound selection. Rules for unwanted groups were defined and selection criteria to enrich for lead-like compounds which facilitate straightforward structure-activity relationship exploration were established. Further, a literature and patent review was undertaken to extract key recognition elements of kinase inhibitors ("core fragments") to assemble a focused library for hit discovery for kinases. Computational and experimental characterisation of the general screening library revealed that the selected compounds 1) span a broad range of lead-like space, 2) show a high degree of structural integrity and purity, and 3) demonstrate appropriate solubility for the purposes of biochemical screening. The implications of this study for compound selection, especially in an academic environment with limited resources, are considered.


Asunto(s)
Química Farmacéutica/métodos , Técnicas Químicas Combinatorias/métodos , Bases de Datos Factuales , Diseño de Fármacos , Biblioteca de Péptidos , Preparaciones Farmacéuticas , Inhibidores de Proteínas Quinasas/farmacología , Preparaciones Farmacéuticas/análisis , Preparaciones Farmacéuticas/química , Inhibidores de Proteínas Quinasas/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...